BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20800633)

  • 1. Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells.
    Castorina A; Giunta S; Mazzone V; Cardile V; D'Agata V
    Peptides; 2010 Dec; 31(12):2276-83. PubMed ID: 20800633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACAP and VIP prevent apoptosis in schwannoma cells.
    Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
    Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1.
    Njaine B; Martins RA; Santiago MF; Linden R; Silveira MS
    Eur J Neurosci; 2010 Aug; 32(3):311-21. PubMed ID: 20646049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide promote the genesis of calcium currents in differentiating mouse embryonic stem cells.
    Chafai M; Basille M; Galas L; Rostene W; Gressens P; Vaudry H; Gonzalez BJ; Louiset E
    Neuroscience; 2011 Dec; 199():103-15. PubMed ID: 22001490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.
    St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR
    Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells.
    Falktoft B; Georg B; Fahrenkrug J
    Neuropeptides; 2009 Oct; 43(5):387-96. PubMed ID: 19712974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
    Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
    Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization, expression, and functional activity of pituitary adenylate cyclase-activating polypeptide and its receptors in human granulosa-luteal cells.
    Morelli MB; Barberi M; Gambardella A; Borini A; Cecconi S; Coticchio G; Canipari R
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4924-32. PubMed ID: 18782879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACAP promotes neural stem cell proliferation in adult mouse brain.
    Mercer A; Rönnholm H; Holmberg J; Lundh H; Heidrich J; Zachrisson O; Ossoinak A; Frisén J; Patrone C
    J Neurosci Res; 2004 Apr; 76(2):205-15. PubMed ID: 15048918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple signal pathways coupling VIP and PACAP receptors to calcium channels in hamster submandibular ganglion neurons.
    Kamaishi H; Endoh T; Suzuki T
    Auton Neurosci; 2004 Mar; 111(1):15-26. PubMed ID: 15109935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout.
    Le Mével JC; Lancien F; Mimassi N; Conlon JM
    J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective role of the VIP signaling system.
    Dvoráková MC
    Drug News Perspect; 2005; 18(6):387-91. PubMed ID: 16247516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.